< 生产厂家价格 >

D-(+)-塔洛糖

D-(+)-塔洛糖用途

D-(+)-Talose是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

点击显示

D-(+)-塔洛糖名称

[ CAS 号 ]:
2595-98-4

[ 中文名 ]:
α-D-(+)-塔罗糖

[ 英文名 ]:
d-talose

[中文别名 ]:

[英文别名 ]:

D-Talose
TALOSE,D
MFCD00135834
D-(+)-Talose
EINECS 219-996-5

D-(+)-塔洛糖生物活性

[ 描述 ]:

D-(+)-Talose是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

D-(+)-塔洛糖物理化学性质

[ 密度 ]:
1.581 g/cm3

[ 沸点 ]:
527.1ºC at 760 mmHg

[ 熔点 ]:
124-127ºC

[ 分子式 ]:
C₆H₁₂O₆

[ 分子量 ]:
180.15600

[ 闪点 ]:
286.7ºC

[ 精确质量 ]:
180.06300

[ PSA ]:
118.22000

[ 外观性状 ]:
白色细结晶粉末

[ 蒸汽压 ]:
1.83E-08mmHg at 25°C

[ 折射率 ]:
22 ° (C=1, H2O)

[ 储存条件 ]:
室温

[ 水溶解性 ]:
H2O: 0.1 g/mL, clear, colorless

D-(+)-塔洛糖MSDS

详细MSDS(安全技术说明书)

D-(+)-塔洛糖安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
24/25-36-26

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2912491000

D-(+)-塔洛糖上下游产品

D-(+)-塔洛糖上游产品

D-(+)-塔洛糖下游产品

D-(+)-塔洛糖海关

[ 海关编码 ]: 2912491000

[ 中文概述 ]:
2912491000. 醛醇. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:5.5%. 普通关税:30.0%

[ Summary ]:
2912491000. other aldehyde-alcohols. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%

D-(+)-塔洛糖文献

Functions of Armigeres subalbatus C-type lectins in innate immunity.

Insect Biochem. Mol. Biol. 52 , 102-14, (2014)

C-type lectins (CTLs) are a superfamily of calcium-dependent carbohydrate binding proteins containing at least one carbohydrate-recognition domain (CRD) and they are present in almost all metazoans. I...

Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus.

Evid. Based. Complement. Alternat. Med. 2012 , 968083, (2012)

Metabolic profiling is widely used as a probe in diagnosing diseases. In this study, the metabolic profiling of urinary carbohydrates was investigated using gas chromatography/mass spectrometry (GC/MS...

An invertebrate hyperglycemic model for the identification of anti-diabetic drugs.

PLoS ONE 6 , e18292, (2011)

The number of individuals diagnosed with type 2 diabetes mellitus, which is caused by insulin resistance and/or abnormal insulin secretion, is increasing worldwide, creating a strong demand for the de...

更多文献